These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23573823)

  • 41. Haematological splenectomy. Changing indications and complications.
    Ketley NJ; Mills MJ; Traub NE; Brown AA
    Clin Lab Haematol; 1992; 14(3):179-88. PubMed ID: 1451397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics and outcomes of young adults with Philadelphia-negative myeloproliferative neoplasms.
    Barzilai M; Kirgner I; Avivi I; Ellis M; Dally N; Rozovski U; Lavi N
    Eur J Haematol; 2019 Jun; 102(6):504-508. PubMed ID: 30941804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.
    Tefferi A; Mudireddy M; Gangat N; Hanson CA; Ketterling RP; Pardanani A; Nagorney DM
    Am J Hematol; 2017 Nov; 92(11):1187-1192. PubMed ID: 28782256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism.
    Filippova OT; Kim SW; Cowan RA; Chi AJ; Iasonos A; Zhou QC; Broach V; Zivanovic O; Long Roche K; Sonoda Y; Gardner G; Chi DS
    Int J Gynecol Cancer; 2020 Aug; 30(8):1183-1188. PubMed ID: 32665236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of open splenectomy for hematologic malignancy with splenomegaly: a contemporary perspective.
    Pata G; Damiani E; Tognali D; Solaini L; Watt J; Ragni F
    Am Surg; 2015 Apr; 81(4):414-20. PubMed ID: 25831190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.
    Ianotto JC; Chauveau A; Boyer-Perrard F; Gyan E; Laribi K; Cony-Makhoul P; Demory JL; de Renzis B; Dosquet C; Rey J; Roy L; Dupriez B; Knoops L; Legros L; Malou M; Hutin P; Ranta D; Benbrahim O; Ugo V; Lippert E; Kiladjian JJ
    Haematologica; 2018 Mar; 103(3):438-446. PubMed ID: 29217781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT).
    Polverelli N; Mauff K; Kröger N; Robin M; Beelen D; Beauvais D; Chevallier P; Mohty M; Passweg J; Rubio MT; Maertens J; Finke J; Bornhäuser M; Vrhovac R; Helbig G; Mear JB; Castagna L; Reményi P; Angelucci E; Karakasis D; Rifòn J; Sirait T; Russo D; de Wreede L; Czerw T; Hernández-Boluda JC; Hayden P; McLornan D; Yakoub-Agha I
    Am J Hematol; 2021 Jan; 96(1):69-79. PubMed ID: 33064301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic Splenectomy for Massive Splenomegaly: Does Size Matter?
    Tsamalaidze L; Stauffer JA; Permenter SL; Asbun HJ
    J Laparoendosc Adv Surg Tech A; 2017 Oct; 27(10):1009-1014. PubMed ID: 28799827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia.
    Benbassat J; Gilon D; Penchas S
    Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
    Strati P; Bose P; Lyle L; Gaw K; Zhou L; Pierce SA; Huynh-Lu J; Hirsch-Ginsberg CF; Bueso-Mendoza DE; Bueso-Ramos CE; Verstovsek S
    Ann Hematol; 2017 May; 96(5):733-738. PubMed ID: 28247057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia.
    Barosi G; Ambrosetti A; Centra A; Falcone A; Finelli C; Foa P; Grossi A; Guarnone R; Rupoli S; Luciano L; Petti MC; Pogliani E; Russo D; Ruggeri M; Quaglini S
    Blood; 1998 May; 91(10):3630-6. PubMed ID: 9572998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dilutional anemia of splenomegaly: an indication for splenectomy.
    Hess CE; Ayers CR; Wetzel RA; Mohler DN; Sandusky WR
    Ann Surg; 1971 May; 173(5):693-9. PubMed ID: 5283024
    [No Abstract]   [Full Text] [Related]  

  • 54. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
    Coleman TA; Hamill RL; Ford SM
    Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
    [No Abstract]   [Full Text] [Related]  

  • 55. Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation.
    Li Z; Deeg HJ
    Leukemia; 2001 Mar; 15(3):465-7. PubMed ID: 11237072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
    Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
    Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Splenectomy in haematology--a 5-year single centre experience.
    Wood L; Baker PM; Martindale A; Jacobs P
    Hematology; 2005 Dec; 10(6):505-9. PubMed ID: 16321816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Massive hepatomegaly following splenectomy for myeloid metaplasia.
    Grieco A; Manna R; Mancini R; Gambassi G
    Am J Med; 1988 Apr; 84(4):797. PubMed ID: 3400674
    [No Abstract]   [Full Text] [Related]  

  • 60. Massive splenomegaly is associated with significant morbidity after laparoscopic splenectomy.
    Patel AG; Parker JE; Wallwork B; Kau KB; Donaldson N; Rhodes MR; O'Rourke N; Nathanson L; Fielding G
    Ann Surg; 2003 Aug; 238(2):235-40. PubMed ID: 12894017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.